She’s singing about the psilocybin molecule, which has been a legal mode of healing in Oregon for over a year now. Cuentas is a co-founder of the Cora Center, which opened earlier this year.

Click here for a full investment analysis of Cybin Inc., a speculative play on FDA approval for psychedelic-based treatments.

By way of introduction I am a psychiatric nurse practitioner with decades of experience inpatient and outpatient in addictions medication. I also have vast experience prescribing and treating various ...

The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized ...

He had obtained tabernanthalog, a research molecule designed to mimic ibogaine ... Compass Pathways is poised to seek approval for psilocybin as a medication for treatment-resistant depression ...

Enveric Biosciences (ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the... ByInvesting ...

In an exploration of psychedelic medicine's potential for treating one of psychiatry's most challenging conditions, ...

Permanent bans on the manufacturing of psilocybin — a psychedelic substance found in some mushrooms — and the use of it in service centers were being approved by voters in Jefferson ...

The decision to reduce the company's workforce and pause other pipeline activities to focus entirely on COMP360 has been ...